Oxford University

Scientists in the U.K. developing world’s first vaccine to prevent ovarian cancer

By /

Researchers at the University of Oxford are working on the world’s first ovarian cancer vaccine, aiming to prevent the disease that kills nearly 26,000 women in the European Union every year. The vaccine, called OvarianVax, would train the immune system to recognize and fight back against the earliest stages of ovarian cancer, one of the most common forms of cancer among women which often isn’t detected until a later stage when it’s harder to treat. Cancer Research U.K. will fund the OvarianVax research with up to £600,000 for the effort.

Elderly man

Thousands of people in the U.K. to receive landmark trials for dementia blood tests

By /

Thousands of people across the U.K. who are worried about their memory will receive blood tests for dementia in two trials that doctors hope will help to revolutionize the low diagnosis rate. Teams from the University of Oxford and University College London will lead the trials to research the use of cheap and simple tests to detect proteins for people with early stages of dementia or problems with cognition, with the hope of speeding up diagnosis and reaching more people.

Mushrooms

Nearly 9 in 10 Americans now think using psilocybin is ‘morally positive,’ in dramatic shift in public opinion

By /

Researchers—representing institutions such as the universities of Oxford, Yale, Johns Hopkins, and Grenada—surveyed 795 people on the issue, asking about supervised use specifically for treatment and for well-being enhancement. Participants, the report says, “rated the individual’s decision as morally positive in both contexts.” The study is of note because although psilocybin “has shown promise both as a treatment for psychiatric conditions and as a means of improving well-being in healthy individuals,” authors wrote.

Scroll to Top